Clavis Pharma logo
  • Company
  • Technology
  • Products under development
  • Licensing and Partners
  • Investors
  • News & Events
    • 2010 Press releases
    • 2009 Press releases
    • 2008 Press releases
    • 2007 Press releases
    • 2006 Press releases
    • 2005 Press releases and earlier years
    • News
    • Subscribe
  • Contact us


Search

Subscribe to our newsletter


Terms/Glossary


News & Events
Skriv ut

News Archive


Displaying 71 - 80 of 92 articles


  • |«
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next »
  • »|



6 July 2007
Clavis Pharma announces initiation of malignant melanoma phase II clinical study


15 June 2007
Clavis Pharma presented preliminary clinical data on ELACYT at EHA


14 May 2007
Clavis Pharma appoints Chief Medical Officer


26 April 2007
First Quarter Report 2007


17 April 2007
Clavis Pharma presents preliminary clinical data on ELACYT™ at AACR


6 February 2007
Clavis Pharma announces expansion of ELACYT clinical development program


1 November 2006
Third Quarter Report 2006


18 September 2006
Clavis Pharma and Mount Sinai School of Medicine have entered into collaboration agreement for the development of new cancer drugs


15 August 2006
Second quarter report from Clavis Pharma ASA


7 July 2006
Clavis Pharma ASA listed on the Oslo Stock Exchange today. TICKER CLAVIS


  • |«
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next »
  • »|
Head Office: Parkveien 53 B, NO-0256 Oslo, Norway Tel: +47 24110950 Fax: +47 24110951 Disclaimer